Publication Date
In 2025 | 0 |
Since 2024 | 1 |
Since 2021 (last 5 years) | 2 |
Since 2016 (last 10 years) | 2 |
Since 2006 (last 20 years) | 2 |
Descriptor
Cohort Analysis | 2 |
Randomized Controlled Trials | 2 |
Drug Therapy | 1 |
Evidence | 1 |
Hearing Impairments | 1 |
Intervention | 1 |
Medical Research | 1 |
Models | 1 |
Networks | 1 |
Outcomes of Treatment | 1 |
Patients | 1 |
More ▼ |
Author
Andrea Manca | 1 |
Chiara Zecca | 1 |
Fabio Pellegrini | 1 |
Gabrielle Simoneau | 1 |
Georgia Salanti | 1 |
Jens Kuhle | 1 |
Konstantina Chalkou | 1 |
Leland, Natalie E. | 1 |
Matthias Egger | 1 |
Mormer, Elaine | 1 |
Palmer, Catherine V. | 1 |
More ▼ |
Publication Type
Journal Articles | 2 |
Reports - Descriptive | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Konstantina Chalkou; Tasnim Hamza; Pascal Benkert; Jens Kuhle; Chiara Zecca; Gabrielle Simoneau; Fabio Pellegrini; Andrea Manca; Matthias Egger; Georgia Salanti – Research Synthesis Methods, 2024
Some patients benefit from a treatment while others may do so less or do not benefit at all. We have previously developed a two-stage network meta-regression prediction model that synthesized randomized trials and evaluates how treatment effects vary across patient characteristics. In this article, we extended this model to combine different…
Descriptors: Medical Research, Outcomes of Treatment, Risk, Randomized Controlled Trials
Patterson, Charity G.; Leland, Natalie E.; Mormer, Elaine; Palmer, Catherine V. – Journal of Speech, Language, and Hearing Research, 2022
Purpose: Individual-randomized trials are the gold standard for testing the efficacy and effectiveness of drugs, devices, and behavioral interventions. Health care delivery, educational, and programmatic interventions are often complex, involving multiple levels of change and measurement precluding individual randomization for testing.…
Descriptors: Speech Language Pathology, Randomized Controlled Trials, Intervention, Speech Therapy